PubMed Sosne, G., Qiu, P., Christopherson, P.L., & Wheater, M.K
IGF-1 LR3 1 is a modified version of human IGF-1, extended by 13 amino acids and featuring a substitution at arginine-3 to reduce binding to IGF-binding proteins (IGFBPs)
Units are based on a standard U-100 insulin syringe
Your doctor will recommend a plan based on your goals
Digestive Comfort: High doses of standard oral glutathione can sometimes cause mild bloating or loose stools
Yes, when monitored clinically, IGF-1 LR3 shows predictable receptor activity and a well-tolerated safety profile in preclinical human data, provided glucose and hormone levels are regularly evaluated